title: Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma.
authors.affiliation: Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, FL, USA.
authors.forename: Lejla Mutapcic
authors.initials: LM
authors.lastname: Vajzovic
authors.forename: Timothy G
authors.initials: TG
authors.lastname: Murray
authors.forename: Mohammed A
authors.initials: MA
authors.lastname: Aziz-Sultan
authors.forename: Amy C
authors.initials: AC
authors.lastname: Schefler
authors.forename: Cristina E
authors.initials: CE
authors.lastname: Fernandes
authors.forename: Stacey C Quintero
authors.initials: SC
authors.lastname: Wolfe
authors.forename: Ditte J
authors.initials: DJ
authors.lastname: Hess
authors.forename: Sander R
authors.initials: SR
authors.lastname: Dubovy
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D002675:Child, Preschool; D015353:Eye Enucleation; D005260:Female; D006801:Humans; D007223:Infant; D007261:Infusions, Intra-Arterial; D008297:Male; D008558:Melphalan / Q000627:therapeutic use*; D009880:Ophthalmic Artery; D019572:Retinal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D012175:Retinoblastoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan